WASHINGTON — There is growing momentum for lawmakers to push forward with the CREATES Act — a long-stalled measure that proponents say will help bring generic drugs to market faster and lower drug prices — according to both supporters and opponents of the bill.
Part of that momentum comes as branded drug makers, who had initially pushed back on the legislation, have relaxed their outright opposition to the measure, according to lobbyists both for branded drug makers and for other industries that support the legislation.
About the Author Reprints
